# Incruse Ellipta

NDC: 0173-0873
Generic name: umeclidinium
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: AEROSOL, POWDER
Routes: ORAL
Marketing started: 20140430

FDA application: NDA205382

## Active ingredients

- UMECLIDINIUM BROMIDE: 62.5 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0173-0873"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0873